Catalyst Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 19.43 M | $405.40 M | 2.14% | 16.33% |
| VANGUARD GROUP INC | 02/11/2025 | 8.43 M | $175.96 M | 4.85% | 7.09% |
| STATE STREET CORP | 02/14/2025 | 5.80 M | $120.97 M | 1.96% | 4.87% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 02/14/2025 | 3.13 M | $65.39 M | -49.71% | 2.63% |
| DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 3.01 M | $62.88 M | -0.19% | 2.53% |
| PACER ADVISORS, INC. | 01/22/2025 | 2.96 M | $61.68 M | 5.40% | 2.49% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 2.80 M | $58.49 M | 90.35% | 2.36% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 2.71 M | $56.48 M | 7.13% | 2.28% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 2.67 M | $55.64 M | 0.04% | 2.24% |
| FIRST TRUST ADVISORS LP | 02/13/2025 | 2.23 M | $46.62 M | -8.03% | 1.88% |
| ROYCE & ASSOCIATES LP | 02/10/2025 | 1.86 M | $38.91 M | -7.76% | 1.57% |
| NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 1.30 M | $27.22 M | 14.51% | 1.10% |
| BOSTON PARTNERS | 02/11/2025 | 1.29 M | $27.32 M | 1.30% | 1.09% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 1.25 M | $26.02 M | 6.78% | 1.05% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/14/2025 | 1.22 M | $25.37 M | -1.53% | 1.02% |
| KENNEDY CAPITAL MANAGEMENT LLC | 02/13/2025 | 1.02 M | $21.24 M | -2.28% | 0.86% |
| INVESCO LTD. | 02/13/2025 | 846,851 | $17.67 M | -9.86% | 0.71% |
| LSV ASSET MANAGEMENT | 02/13/2025 | 777,124 | $16.22 M | -18.31% | 0.65% |
| MESIROW INSTITUTIONAL INVESTMENT MANAGEMENT, INC. | 02/13/2025 | 742,295 | $15.49 M | -7.31% | 0.62% |
| JPMORGAN CHASE & CO | 02/12/2025 | 736,197 | $15.36 M | 80.33% | 0.62% |
| SKANDINAVISKA ENSKILDA BANKEN AB (PUBL) | 02/10/2025 | 731,900 | $15.42 M | 74.30% | 0.62% |
| BANK OF NEW YORK MELLON CORP | 02/04/2025 | 723,545 | $15.10 M | 1.29% | 0.61% |
| UBS GROUP AG | 02/14/2025 | 722,858 | $15.09 M | 239.62% | 0.61% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 02/12/2025 | 698,152 | $14.57 M | 131.45% | 0.59% |
| MACQUARIE GROUP LTD | 02/14/2025 | 682,652 | $14.25 M | 100.00% | 0.57% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/14/2025 | 659,252 | $13.76 M | -1.20% | 0.55% |
| PRINCIPAL FINANCIAL GROUP INC | 01/31/2025 | 600,488 | $12.53 M | 4.26% | 0.50% |
| PRUDENTIAL FINANCIAL INC | 02/11/2025 | 553,424 | $11.55 M | 30.25% | 0.47% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 02/14/2025 | 531,836 | $11.10 M | -30.68% | 0.45% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 520,778 | $10.87 M | -6.97% | 0.44% |
| ABRDN PLC | 01/24/2025 | 484,666 | $10.11 M | 100.00% | 0.41% |
| JUPITER ASSET MANAGEMENT LTD | 02/10/2025 | 481,987 | $10.06 M | -31.14% | 0.41% |
| AQR CAPITAL MANAGEMENT LLC | 02/14/2025 | 477,011 | $9.96 M | 3.84% | 0.40% |
| JANUS HENDERSON GROUP PLC | 02/14/2025 | 476,023 | $9.94 M | 32.16% | 0.40% |
| OBERWEIS ASSET MANAGEMENT INC/ | 02/14/2025 | 467,100 | $9.75 M | 1.90% | 0.39% |
| GABLES CAPITAL MANAGEMENT INC. | 02/07/2025 | 417,551 | $8.71 M | -2.27% | 0.35% |
| ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC | 01/29/2025 | 417,332 | $8.71 M | 13.89% | 0.35% |
| JW ASSET MANAGEMENT, LLC | 02/07/2025 | 413,392 | $8.63 M | 0.00% | 0.35% |
| IKARIAN CAPITAL, LLC | 02/14/2025 | 349,649 | $7.30 M | -16.32% | 0.29% |
| LEGAL & GENERAL GROUP PLC | 02/13/2025 | 344,623 | $7.19 M | 2.91% | 0.29% |
| RAYMOND JAMES FINANCIAL INC | 02/13/2025 | 329,980 | $6.89 M | 100.00% | 0.28% |
| MAN GROUP PLC | 02/14/2025 | 315,817 | $6.59 M | 24.00% | 0.27% |
| RHUMBLINE ADVISERS | 01/30/2025 | 312,320 | $6.52 M | 0.31% | 0.26% |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 02/14/2025 | 300,000 | $6.26 M | -25.00% | 0.25% |
| VICTORY CAPITAL MANAGEMENT INC | 02/06/2025 | 296,080 | $6.18 M | 1.57% | 0.25% |
| AMERIPRISE FINANCIAL INC | 02/14/2025 | 282,834 | $5.90 M | 1.86% | 0.24% |
| PUBLIC SECTOR PENSION INVESTMENT BOARD | 02/14/2025 | 279,479 | $5.83 M | 18.06% | 0.24% |
| UBS ASSET MANAGEMENT AMERICAS INC | 02/14/2025 | 263,905 | $5.51 M | 11.72% | 0.22% |
| ALTIUM CAPITAL MANAGEMENT LP | 02/13/2025 | 255,000 | $5.32 M | -33.77% | 0.21% |
| MARSHALL WACE, LLP | 02/13/2025 | 253,637 | $5.29 M | -70.54% | 0.21% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Catalyst Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 401 institutional investors and hedge funds held shares of Catalyst Pharmaceuticals, Inc.. The most heavily invested institutionals were:
BlackRock Funding, Inc. /DE: 19.43 M
VANGUARD GROUP INC: 8.43 M
STATE STREET CORP: 5.8 M
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C): 3.13 M
DIMENSIONAL FUND ADVISORS LP: 3.01 M
Pacer Advisors, Inc.: 2.96 M
82.04% of Catalyst Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 117.61 M shares in the last 24 months. This purchase volume represents approximately $2.37 B in transactions.